Most Read This Week
- Cardiovascular Outcomes in Patients Initiating First-Line Treatment of Type 2 Diabetes With SGLT2 Inhibitors vs Metformin
- Both Bariatric Surgery Methods Yield Similar 10-Year Results
- Association of Sugar-Sweetened, Artificially Sweetened, and Unsweetened Coffee Consumption With All-Cause and Cause-Specific Mortality
- Tirzepatide Once Weekly for the Treatment of Obesity
- Diet vs Medication for Patients With IBS in Primary Care
Recently Updated
- FDA Tells Vaccine Makers to Update Boosters to Target Omicron Subvariants
- U.S. Orders 105 Million More Pfizer Shots for Fall Booster Campaign
- Two Doses of BNT162b2 Moderately Effective for 5- to 11-Year-Olds
- Prevalence of CRC Screening Remains Low in Those Aged 50 to 54
- COVID-19 Linked to Increased Risk of Neurological Disorders